GlassScriptPhysician profile
Tricia T Gilbert
NPI 1720177090
$5,880.47
in general payments reported to CMS, 2019-2025
42 companies · $1,568 in 2025
The $1,568 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $955 · 2020: $171 · 2021: $392 · 2022: $789 · 2023: $1,007 · 2024: $998 · 2025: $1,568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,556 · Education: $17.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,555.64 |
| Education | $17.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,095.10 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $836.43 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $387.44 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Mylan Specialty L.P. | $329.19 | 2019-2024 | Yupelri |
| Genzyme Corporation | $323.17 | 2021-2025 | |
| Harmony Biosciences LLC | $269.79 | 2021-2025 | Wakix |
| Amgen INC. | $256.59 | 2022-2025 | Tezspire |
| Insmed, INC. | $253.76 | 2019-2025 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $237.76 | 2019-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $164.92 | 2019-2025 | |
| Ani Pharmaceuticals, INC. | $136.75 | 2025 | Purified Cortrophin Gel |
| Grifols USA, LLC | $127.71 | 2022-2025 | Prolastin-C Liquid, Xembify |
| Genentech USA, INC. | $118.38 | 2019-2025 | Xolair |
| Axsome Therapeutics, INC. | $115.00 | 2022-2025 | Sunosi |
| Csl Behring | $113.64 | 2019-2025 | Hizentra |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $112.46 | 2021-2025 | Cuvitru, Aralast |
| Sunovion Pharmaceuticals INC. | $92.49 | 2019-2020 | |
| Viatris Specialty LLC | $72.35 | 2025 | Yupelri |
| Boston Scientific Corporation | $68.63 | 2022-2023 | Watchman Access System, Watchman |
| Merck Sharp & Dohme LLC | $67.57 | 2021-2024 | Zerbaxa, Dificid, Recarbrio |
| Avadel Cns Pharmaceuticals, LLC | $62.25 | 2023-2025 | Lumryz |
| Astellas Pharma US INC | $61.90 | 2020 | |
| Inspire Medical Systems, INC. | $56.03 | 2024-2025 | Inspire |
| Baxter Healthcare | $47.18 | 2023-2025 | Hillrom - Life 2000 Ventilation System |
| Inogen, INC. | $46.81 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Mallinckrodt Hospital Products INC. | $43.00 | 2021-2023 | Acthar |
| Mallinckrodt Enterprises LLC | $41.58 | 2019 | |
| Lilly USA, LLC | $36.75 | 2025 | Zepbound |
| Verona Pharma, INC. | $36.17 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $29.05 | 2019 | |
| Pfizer INC. | $29.00 | 2019-2021 | |
| Advanced Respiratory, INC | $27.89 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $25.64 | 2022 | |
| Zoll Respicardia, INC. | $25.03 | 2025 | Remede System |
| Bayer Healthcare Pharmaceuticals INC. | $22.55 | 2024 | |
| Sanofi-Aventis U.S. LLC | $20.70 | 2024 | |
| United Therapeutics Corporation | $18.08 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.26 | 2022 | |
| Jazz Pharmaceuticals INC. | $15.23 | 2021 | |
| Pulmonx Corporation | $14.26 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Shire North American Group INC | $13.94 | 2019 | |
| Sanofi Pasteur INC. | $13.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tricia Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.